CA2248328A1 - Catheter orientable a extremites alignables dote d'un detecteur de surface - Google Patents

Catheter orientable a extremites alignables dote d'un detecteur de surface Download PDF

Info

Publication number: CA2248328A1
Authority: CA; Canada
Prior art keywords: catheter; deflection; distal end; jacket; functional device
Prior art date: 1997-09-24
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA 2248328

Other languages

English (en)

Inventor

Michael Horzewski

Richard L. Mueller

Stuart D. Harman

Michael Rosinko

Douglas Murphy-Chutorian

Alexander Khairkhahan

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Eclipse Surgical Technologies Inc

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-09-24

Filing date

1998-09-22

Publication date

1999-03-24

1998-09-22 Application filed by Individual filed Critical Individual

1999-03-24 Publication of CA2248328A1 publication Critical patent/CA2248328A1/fr

Status Abandoned legal-status Critical Current

Links

238000011282 treatment Methods 0.000 claims abstract description 22
238000001514 detection method Methods 0.000 claims abstract description 9
238000000034 method Methods 0.000 claims description 67
239000003814 drug Substances 0.000 claims description 61
230000007246 mechanism Effects 0.000 claims description 59
229940079593 drug Drugs 0.000 claims description 52
238000012377 drug delivery Methods 0.000 claims description 31
230000033001 locomotion Effects 0.000 claims description 29
239000012530 fluid Substances 0.000 claims description 28
239000013307 optical fiber Substances 0.000 claims description 27
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 20
210000004165 myocardium Anatomy 0.000 claims description 17
239000011780 sodium chloride Substances 0.000 claims description 17
210000005240 left ventricle Anatomy 0.000 claims description 13
230000000638 stimulation Effects 0.000 claims description 13
239000003795 chemical substances by application Substances 0.000 claims description 12
210000005166 vasculature Anatomy 0.000 claims description 9
229940124597 therapeutic agent Drugs 0.000 claims description 8
238000007789 sealing Methods 0.000 claims description 7
238000002604 ultrasonography Methods 0.000 claims description 7
230000008878 coupling Effects 0.000 claims description 5
238000010168 coupling process Methods 0.000 claims description 5
238000005859 coupling reaction Methods 0.000 claims description 5
230000003247 decreasing effect Effects 0.000 claims description 3
230000000694 effects Effects 0.000 claims description 3
230000004913 activation Effects 0.000 claims description 2
230000033115 angiogenesis Effects 0.000 claims description 2
230000000670 limiting effect Effects 0.000 claims description 2
238000012544 monitoring process Methods 0.000 claims description 2
238000005086 pumping Methods 0.000 claims 3
210000002216 heart Anatomy 0.000 abstract description 27
230000000250 revascularization Effects 0.000 abstract description 5
239000000835 fiber Substances 0.000 description 53
108091006146 Channels Proteins 0.000 description 43
210000001519 tissue Anatomy 0.000 description 20
239000000463 material Substances 0.000 description 17
230000002107 myocardial effect Effects 0.000 description 11
230000008901 benefit Effects 0.000 description 9
210000000056 organ Anatomy 0.000 description 9
238000013519 translation Methods 0.000 description 9
239000008280 blood Substances 0.000 description 8
210000004369 blood Anatomy 0.000 description 8
229910045601 alloy Inorganic materials 0.000 description 7
239000000956 alloy Substances 0.000 description 7
238000013461 design Methods 0.000 description 7
239000000243 solution Substances 0.000 description 7
230000001965 increasing effect Effects 0.000 description 6
238000002347 injection Methods 0.000 description 6
239000007924 injection Substances 0.000 description 6
238000001356 surgical procedure Methods 0.000 description 6
239000010936 titanium Substances 0.000 description 6
238000012800 visualization Methods 0.000 description 6
229910001000 nickel titanium Inorganic materials 0.000 description 5
230000036961 partial effect Effects 0.000 description 5
PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical group [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 4
238000001574 biopsy Methods 0.000 description 4
230000006870 function Effects 0.000 description 4
238000003973 irrigation Methods 0.000 description 4
230000004048 modification Effects 0.000 description 4
238000012986 modification Methods 0.000 description 4
239000012781 shape memory material Substances 0.000 description 4
238000002560 therapeutic procedure Methods 0.000 description 4
238000002679 ablation Methods 0.000 description 3
230000009471 action Effects 0.000 description 3
238000001467 acupuncture Methods 0.000 description 3
230000002491 angiogenic effect Effects 0.000 description 3
210000005242 cardiac chamber Anatomy 0.000 description 3
150000001875 compounds Chemical class 0.000 description 3
238000010276 construction Methods 0.000 description 3
230000007423 decrease Effects 0.000 description 3
238000009792 diffusion process Methods 0.000 description 3
210000001174 endocardium Anatomy 0.000 description 3
KHYBPSFKEHXSLX-UHFFFAOYSA-N iminotitanium Chemical compound [Ti]=N KHYBPSFKEHXSLX-UHFFFAOYSA-N 0.000 description 3
238000001802 infusion Methods 0.000 description 3
230000002262 irrigation Effects 0.000 description 3
239000007788 liquid Substances 0.000 description 3
239000000203 mixture Substances 0.000 description 3
239000011295 pitch Substances 0.000 description 3
230000004044 response Effects 0.000 description 3
239000000523 sample Substances 0.000 description 3
230000001225 therapeutic effect Effects 0.000 description 3
-1 thrombolytics Substances 0.000 description 3
229910052719 titanium Inorganic materials 0.000 description 3
230000002792 vascular Effects 0.000 description 3
206010028980 Neoplasm Diseases 0.000 description 2
RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 2
102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 2
108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 2
238000002399 angioplasty Methods 0.000 description 2
239000003416 antiarrhythmic agent Substances 0.000 description 2
239000003146 anticoagulant agent Substances 0.000 description 2
229940127219 anticoagulant drug Drugs 0.000 description 2
206010003119 arrhythmia Diseases 0.000 description 2
230000006793 arrhythmia Effects 0.000 description 2
210000001367 artery Anatomy 0.000 description 2
230000000712 assembly Effects 0.000 description 2
238000000429 assembly Methods 0.000 description 2
238000010009 beating Methods 0.000 description 2
239000002876 beta blocker Substances 0.000 description 2
230000036770 blood supply Effects 0.000 description 2
230000008859 change Effects 0.000 description 2
238000007906 compression Methods 0.000 description 2
230000006835 compression Effects 0.000 description 2
238000001816 cooling Methods 0.000 description 2
238000006073 displacement reaction Methods 0.000 description 2
230000002526 effect on cardiovascular system Effects 0.000 description 2
238000001415 gene therapy Methods 0.000 description 2
239000003102 growth factor Substances 0.000 description 2
238000010438 heat treatment Methods 0.000 description 2
230000001939 inductive effect Effects 0.000 description 2
230000003902 lesion Effects 0.000 description 2
239000003550 marker Substances 0.000 description 2
239000012528 membrane Substances 0.000 description 2
HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 2
230000003287 optical effect Effects 0.000 description 2
239000002831 pharmacologic agent Substances 0.000 description 2
230000000144 pharmacologic effect Effects 0.000 description 2
238000011084 recovery Methods 0.000 description 2
239000007787 solid Substances 0.000 description 2
239000011343 solid material Substances 0.000 description 2
230000001988 toxicity Effects 0.000 description 2
231100000419 toxicity Toxicity 0.000 description 2
230000002861 ventricular Effects 0.000 description 2
239000005541 ACE inhibitor Substances 0.000 description 1
229940127291 Calcium channel antagonist Drugs 0.000 description 1
208000006017 Cardiac Tamponade Diseases 0.000 description 1
102000008186 Collagen Human genes 0.000 description 1
108010035532 Collagen Proteins 0.000 description 1
241000938605 Crocodylia Species 0.000 description 1
102000009024 Epidermal Growth Factor Human genes 0.000 description 1
208000000624 Esophageal and Gastric Varices Diseases 0.000 description 1
102000003974 Fibroblast growth factor 2 Human genes 0.000 description 1
108090000379 Fibroblast growth factor 2 Proteins 0.000 description 1
206010016654 Fibrosis Diseases 0.000 description 1
230000005355 Hall effect Effects 0.000 description 1
229910052689 Holmium Inorganic materials 0.000 description 1
241000282412 Homo Species 0.000 description 1
206010058179 Hypertensive emergency Diseases 0.000 description 1
229910000990 Ni alloy Inorganic materials 0.000 description 1
101710098940 Pro-epidermal growth factor Proteins 0.000 description 1
241000208332 Rauvolfia Species 0.000 description 1
229910000639 Spring steel Inorganic materials 0.000 description 1
208000007536 Thrombosis Diseases 0.000 description 1
206010056091 Varices oesophageal Diseases 0.000 description 1
230000003213 activating effect Effects 0.000 description 1
230000001154 acute effect Effects 0.000 description 1
230000001800 adrenalinergic effect Effects 0.000 description 1
239000000674 adrenergic antagonist Substances 0.000 description 1
239000002160 alpha blocker Substances 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
238000004873 anchoring Methods 0.000 description 1
239000003098 androgen Substances 0.000 description 1
239000002333 angiotensin II receptor antagonist Substances 0.000 description 1
229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 description 1
239000005557 antagonist Substances 0.000 description 1
230000003288 anthiarrhythmic effect Effects 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
229940046836 anti-estrogen Drugs 0.000 description 1
230000001833 anti-estrogenic effect Effects 0.000 description 1
230000001567 anti-fibrinolytic effect Effects 0.000 description 1
230000000340 anti-metabolite Effects 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
239000000504 antifibrinolytic agent Substances 0.000 description 1
229940082620 antifibrinolytics Drugs 0.000 description 1
229940125715 antihistaminic agent Drugs 0.000 description 1
239000000739 antihistaminic agent Substances 0.000 description 1
239000002256 antimetabolite Substances 0.000 description 1
229940100197 antimetabolite Drugs 0.000 description 1
210000002376 aorta thoracic Anatomy 0.000 description 1
210000001765 aortic valve Anatomy 0.000 description 1
230000013158 artery development Effects 0.000 description 1
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
229940097320 beta blocking agent Drugs 0.000 description 1
229910002056 binary alloy Inorganic materials 0.000 description 1
230000003115 biocidal effect Effects 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
230000036760 body temperature Effects 0.000 description 1
230000037396 body weight Effects 0.000 description 1
210000000988 bone and bone Anatomy 0.000 description 1
239000000480 calcium channel blocker Substances 0.000 description 1
239000002775 capsule Substances 0.000 description 1
230000000747 cardiac effect Effects 0.000 description 1
239000000919 ceramic Substances 0.000 description 1
238000002512 chemotherapy Methods 0.000 description 1
230000004087 circulation Effects 0.000 description 1
230000010405 clearance mechanism Effects 0.000 description 1
229920001436 collagen Polymers 0.000 description 1
238000004891 communication Methods 0.000 description 1
239000004020 conductor Substances 0.000 description 1
210000004351 coronary vessel Anatomy 0.000 description 1
239000002254 cytotoxic agent Substances 0.000 description 1
229940127089 cytotoxic agent Drugs 0.000 description 1
231100000599 cytotoxic agent Toxicity 0.000 description 1
238000003745 diagnosis Methods 0.000 description 1
239000000032 diagnostic agent Substances 0.000 description 1
229940039227 diagnostic agent Drugs 0.000 description 1
239000002934 diuretic Substances 0.000 description 1
229940030606 diuretics Drugs 0.000 description 1
238000002651 drug therapy Methods 0.000 description 1
230000003028 elevating effect Effects 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
239000002532 enzyme inhibitor Substances 0.000 description 1
208000024170 esophageal varices Diseases 0.000 description 1
201000010120 esophageal varix Diseases 0.000 description 1
239000000328 estrogen antagonist Substances 0.000 description 1
210000001105 femoral artery Anatomy 0.000 description 1
230000004761 fibrosis Effects 0.000 description 1
238000010304 firing Methods 0.000 description 1
238000011010 flushing procedure Methods 0.000 description 1
238000009472 formulation Methods 0.000 description 1
239000008187 granular material Substances 0.000 description 1
230000035876 healing Effects 0.000 description 1
208000019622 heart disease Diseases 0.000 description 1
KJZYNXUDTRRSPN-UHFFFAOYSA-N holmium atom Chemical compound [Ho] KJZYNXUDTRRSPN-UHFFFAOYSA-N 0.000 description 1
239000002955 immunomodulating agent Substances 0.000 description 1
229940121354 immunomodulator Drugs 0.000 description 1
230000002584 immunomodulator Effects 0.000 description 1
230000001506 immunosuppresive effect Effects 0.000 description 1
229940125721 immunosuppressive agent Drugs 0.000 description 1
239000007943 implant Substances 0.000 description 1
238000007373 indentation Methods 0.000 description 1
239000003112 inhibitor Substances 0.000 description 1
239000004041 inotropic agent Substances 0.000 description 1
238000003780 insertion Methods 0.000 description 1
230000037431 insertion Effects 0.000 description 1
238000007689 inspection Methods 0.000 description 1
238000013152 interventional procedure Methods 0.000 description 1
150000002500 ions Chemical class 0.000 description 1
208000028867 ischemia Diseases 0.000 description 1
238000013532 laser treatment Methods 0.000 description 1
238000012423 maintenance Methods 0.000 description 1
201000005857 malignant hypertension Diseases 0.000 description 1
210000001161 mammalian embryo Anatomy 0.000 description 1
238000013507 mapping Methods 0.000 description 1
HAWPXGHAZFHHAD-UHFFFAOYSA-N mechlorethamine Chemical class ClCCN(C)CCCl HAWPXGHAZFHHAD-UHFFFAOYSA-N 0.000 description 1
230000004089 microcirculation Effects 0.000 description 1
229910052759 nickel Inorganic materials 0.000 description 1
GWUSZQUVEVMBPI-UHFFFAOYSA-N nimetazepam Chemical compound N=1CC(=O)N(C)C2=CC=C([N+]([O-])=O)C=C2C=1C1=CC=CC=C1 GWUSZQUVEVMBPI-UHFFFAOYSA-N 0.000 description 1
230000008520 organization Effects 0.000 description 1
239000001301 oxygen Substances 0.000 description 1
229910052760 oxygen Inorganic materials 0.000 description 1
208000003278 patent ductus arteriosus Diseases 0.000 description 1
230000037361 pathway Effects 0.000 description 1
238000005325 percolation Methods 0.000 description 1
230000010412 perfusion Effects 0.000 description 1
230000002572 peristaltic effect Effects 0.000 description 1
239000012466 permeate Substances 0.000 description 1
238000002428 photodynamic therapy Methods 0.000 description 1
239000000106 platelet aggregation inhibitor Substances 0.000 description 1
239000011148 porous material Substances 0.000 description 1
239000000047 product Substances 0.000 description 1
230000035755 proliferation Effects 0.000 description 1
230000005855 radiation Effects 0.000 description 1
239000002464 receptor antagonist Substances 0.000 description 1
229940044551 receptor antagonist Drugs 0.000 description 1
230000000717 retained effect Effects 0.000 description 1
238000012552 review Methods 0.000 description 1
238000005070 sampling Methods 0.000 description 1
239000012056 semi-solid material Substances 0.000 description 1
229910001285 shape-memory alloy Inorganic materials 0.000 description 1
230000035939 shock Effects 0.000 description 1
239000010935 stainless steel Substances 0.000 description 1
229910001220 stainless steel Inorganic materials 0.000 description 1
239000000021 stimulant Substances 0.000 description 1
239000000126 substance Substances 0.000 description 1
210000000115 thoracic cavity Anatomy 0.000 description 1
229960000103 thrombolytic agent Drugs 0.000 description 1
230000002537 thrombolytic effect Effects 0.000 description 1
230000001052 transient effect Effects 0.000 description 1
230000007704 transition Effects 0.000 description 1
230000000472 traumatic effect Effects 0.000 description 1
WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
229910052721 tungsten Inorganic materials 0.000 description 1
239000010937 tungsten Substances 0.000 description 1
229960005486 vaccine Drugs 0.000 description 1
229940124549 vasodilator Drugs 0.000 description 1
239000003071 vasodilator agent Substances 0.000 description 1
206010047302 ventricular tachycardia Diseases 0.000 description 1
230000007998 vessel formation Effects 0.000 description 1
239000003643 water by type Substances 0.000 description 1
230000003313 weakening effect Effects 0.000 description 1

Landscapes

Infusion, Injection, And Reservoir Apparatuses (AREA)
Laser Surgery Devices (AREA)
Media Introduction/Drainage Providing Device (AREA)

CA 2248328 1997-09-24 1998-09-22 Catheter orientable a extremites alignables dote d'un detecteur de surface Abandoned CA2248328A1 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US5989297P	1997-09-24	1997-09-24
US60/059,892		1997-09-24

Publications (1)

Publication Number	Publication Date
CA2248328A1 true CA2248328A1 (fr)	1999-03-24

Family

ID=22025958

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
CA 2248328 Abandoned CA2248328A1 (fr)	1997-09-24	1998-09-22	Catheter orientable a extremites alignables dote d'un detecteur de surface
CA 2248025 Abandoned CA2248025A1 (fr)	1997-09-24	1998-09-22	Catheter utilise pour l'administration de medicament avec dispositif d'alignement d'extremite

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
CA 2248025 Abandoned CA2248025A1 (fr)	1997-09-24	1998-09-22	Catheter utilise pour l'administration de medicament avec dispositif d'alignement d'extremite

Country Status (2)

Country	Link
AU (1)	AU8703298A (fr)
CA (2)	CA2248328A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN107213554B (zh) *	2017-07-17	2019-11-19	尚华	一种介入用的液态光传导装置

1998
- 1998-09-22 CA CA 2248328 patent/CA2248328A1/fr not_active Abandoned
- 1998-09-22 CA CA 2248025 patent/CA2248025A1/fr not_active Abandoned
- 1998-09-24 AU AU87032/98A patent/AU8703298A/en not_active Abandoned

Also Published As

Publication number	Publication date
AU8703298A (en)	1999-04-15
CA2248025A1 (fr)	1999-03-24

Legal Events

Date	Code	Title	Description
1999-10-01	EEER	Examination request
2004-09-22	FZDE	Dead

Publication	Publication Date	Title
AU712738B2 (en)	1999-11-18	Steerable catheter
US6554794B1 (en)	2003-04-29	Non-deforming deflectable multi-lumen catheter
US6179809B1 (en)	2001-01-30	Drug delivery catheter with tip alignment
US5876373A (en)	1999-03-02	Steerable catheter
US6176856B1 (en)	2001-01-23	Resistive heating system and apparatus for improving blood flow in the heart
US6123084A (en)	2000-09-26	Method for improving blood flow in the heart
US20220031389A1 (en)	2022-02-03	Catheter for peri-vascular fluid injection
AU730720B2 (en)	2001-03-15	Transvascular TMR device and method
US9011380B2 (en)	2015-04-21	Catheter for introduction of medications to the tissues of a heart or other organ
US6053911A (en)	2000-04-25	Transvascular TMR device and method
US5873865A (en)	1999-02-23	Spiral catheter with multiple guide holes
US7033345B2 (en)	2006-04-25	Deflectable microimplant delivery system
US5730741A (en)	1998-03-24	Guided spiral catheter
US20030032936A1 (en)	2003-02-13	Side-exit catheter and method for its use
EP0853921A2 (fr)	1998-07-22	Administration de médicaments assistée par laser
US20110288469A1 (en)	2011-11-24	Surgical device and method for performing combination revascularization and therapeutic substance delivery to tissue
US20170020567A1 (en)	2017-01-26	Catheter System for Left Heart Access
CA2248025A1 (fr)	1999-03-24	Catheter utilise pour l'administration de medicament avec dispositif d'alignement d'extremite